Endotronix

Endotronix Closes Expanded Series D Round.

Lisle, Illinois & Dublin, Ireland.  Oct 1, 2019.  Seroba’s investee company, Endotronix, Inc., a digital health, medtech company dedicated to advancing the treatment of heart failure (HF), today announced the expansion of its Series D financing […]

Read more

FDA Approval for Endotronix Pivotal Trial.

Dublin, Ireland and Lisle, Illinois, USA.  August 1, 2019.  Seroba’s portfolio company, Endotronix, Inc., a digital health and medical technology company dedicated to advancing the treatment of heart failure (HF), today announced it has received conditional […]

Read more

Endotronix Enrolls 1st Patient in SIRONA II CE Mark Trial.

Lisle, Illinois.  July 15, 2019.  Endotronix, Inc., a digital health and medical technology company dedicated to advancing the treatment of heart failure, today announced enrollment of the first patient in its prospective, multi-center, SIRONA II trial, […]

Read more

Endotronix Raises $45M Series D Financing.

Ireland and USA.  14 Sept 2018. Endotronix, Inc., a digital health, medtech company dedicated to advancing the treatment of heart failure, today announced the close of a Series D financing round totaling $45 million. The round […]

Read more

We use cookies and analytics to improve your online experience and to help us to understand where our audience is and how they reach us, as well as to understand what topics and site features are of greatest interest.  To find out more, please read our Privacy Policy. By clicking on the Accept button, you consent to our use of cookies and browsing analytics.

Scroll to Top